These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28700045)
21. Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico. Manne-Goehler J; Ramsey JM; Salgado MO; Wirtz VJ; Reich MR Am J Trop Med Hyg; 2014 Dec; 91(6):1125-7. PubMed ID: 25266353 [TBL] [Abstract][Full Text] [Related]
24. Experimental and Clinical Treatment of Chagas Disease: A Review. Sales Junior PA; Molina I; Fonseca Murta SM; Sánchez-Montalvá A; Salvador F; Corrêa-Oliveira R; Carneiro CM Am J Trop Med Hyg; 2017 Nov; 97(5):1289-1303. PubMed ID: 29016289 [TBL] [Abstract][Full Text] [Related]
25. An overview of Chagas disease treatment. Jannin J; Villa L Mem Inst Oswaldo Cruz; 2007 Oct; 102 Suppl 1():95-7. PubMed ID: 17906803 [TBL] [Abstract][Full Text] [Related]
26. FDA Gives First-Ever Approval of Drug To Treat Chagas' Disease. Morrow T Manag Care; 2017 Nov; 26(11):38-40. PubMed ID: 29185981 [TBL] [Abstract][Full Text] [Related]
27. Tolerance of benznidazole in a United States Chagas Disease clinic. Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454 [TBL] [Abstract][Full Text] [Related]
28. [Postpartum treatment without interrupting breastfeeding in a patient with Chagas disease]. Vela-Bahena LE; Vergara R; Vite L; Ramos C Ginecol Obstet Mex; 2015 Aug; 83(8):487-93. PubMed ID: 26591033 [TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions. Correia JPR; Costa ACD; Rocha EA; Quidute ARP; Cândido DDS; Ponciano ÂMS; Fonteles MMF; Oliveira MF Rev Soc Bras Med Trop; 2017; 50(3):334-340. PubMed ID: 28700051 [TBL] [Abstract][Full Text] [Related]
30. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Carrilero B; Murcia L; Martínez-Lage L; Segovia M Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093 [TBL] [Abstract][Full Text] [Related]
31. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280 [TBL] [Abstract][Full Text] [Related]
32. [What is not searched, it is difficult to find: Chagas' disease]. Briceno L; Mosca W G Ital Cardiol (Rome); 2016 May; 17(5):343-7. PubMed ID: 27310907 [TBL] [Abstract][Full Text] [Related]
33. "We have already heard that the treatment doesn't do anything, so why should we take it?": A mixed method perspective on Chagas disease knowledge, attitudes, prevention, and treatment behaviour in the Bolivian Chaco. Parisi S; Navarro M; Du Plessis JD; Shock JP; Apodaca Michel B; Lucuy Espinoza M; Terán C; Calizaya Tapia NA; Oltmanns K; Baptista Mora A; Saveedra Irala C; Rivera Rojas AA; Rubilar G; Zoller T; Pritsch M PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008752. PubMed ID: 33119632 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease. Fragata-Filho AA; França FF; Fragata Cda S; Lourenço AM; Faccini CC; Costa CA PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004508. PubMed ID: 26974551 [TBL] [Abstract][Full Text] [Related]
35. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil. Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658 [TBL] [Abstract][Full Text] [Related]
36. Arthritis and benznidazole: more closely related than we thought. Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100 [TBL] [Abstract][Full Text] [Related]
37. Chagas disease: Present status of pathogenic mechanisms and chemotherapy. Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304 [TBL] [Abstract][Full Text] [Related]
38. The treatment of Chagas disease (South American trypanosomiasis). Pinto Dias JC Ann Intern Med; 2006 May; 144(10):772-4. PubMed ID: 16702594 [No Abstract] [Full Text] [Related]
39. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138 [TBL] [Abstract][Full Text] [Related]
40. Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review. Imai K; Maeda T; Sayama Y; Osa M; Mikita K; Kurane I; Miyahira Y; Kawana A; Miura S Parasitol Int; 2015 Oct; 64(5):240-2. PubMed ID: 25744336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]